Superworth

Lemaitre Vascular PE ratio LMAT

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Nov 2, 2026
28.5×
10-year median
42.0×
Against its 10-year history
11th
percentile: 0 is its lowest day, 100 its highest
10-year range
21.4× to 73.3×
Peer median
40.7×

Lemaitre Vascular's PE ratio is 28.5× as of Nov 2, 2026: a share price of $81.26 against $2.85 of earnings per share over the last twelve months.

That is below its ten-year median of 42.0×, lower than on 89% of days in the last ten years.

Over that time it ranged from 21.4× in Dec 2018 to 73.3× in Jun 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 40.7×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far28.5×27.7×45.7×
202536.1×35.8×54.4×
202450.7×44.6×59.0×
202346.9×40.1×73.3×
202247.9×31.1×54.2×
202138.1×35.5×55.3×
202043.5×24.3×43.5×
201938.1×21.8×39.0×
201822.6×21.4×47.6×
201741.4×40.3×56.6×
201646.1×30.4×46.1×
201543.1×31.3×48.4×
201444.5×37.6×55.9×
201340.5×34.2×49.2×
201245.0×33.3×50.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.

CompanyPE ratio
LMATLemaitre Vascular28.5×
INSPInspire Medical Systems14.5×
UFPTUFP Technologies30.6×
EYENational Vision28.1×
CDRECadre38.9×
STAAStaar Surgical356×
WRBYWarby Parker341×
ATRCAtriCure285×
BVSBioventus17.1×
IARTIntegra Lifesciences80.1×
IRMDIradimed42.5×
Peer median40.7×

Where Lemaitre Vascular ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Lemaitre Vascular

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.